Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of PDE8B protein | affects expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of PDE8B mRNA | decreases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PDE8B mRNA | decreases expression | 19150397 20018196
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of PDE8B mRNA | decreases expression | 20106945
|
C459562 |
L-826,141 |
L-826,141 results in decreased activity of PDE8B protein | decreases activity | 15901792
|
D008094 |
Lithium |
Lithium results in decreased expression of PDE8B mRNA | decreases expression | 20222156
|
C076029 |
olanzapine |
olanzapine results in increased expression of PDE8B mRNA | increases expression | 20222156
|
C424423 |
Roflumilast |
Roflumilast results in decreased activity of PDE8B protein | decreases activity | 15901792
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PDE8B mRNA | decreases expression | 20106945
|
C035964 |
trequinsin |
trequinsin results in decreased activity of PDE8B protein | decreases activity | 15901792
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.08 | 15322242 11752688 14514962 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.02 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.74 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.61 | 16835633 |
MESH:D000312 |
Adrenal Hyperplasia, Congenital |
marker/mechanism |
|
| |
MESH:D000544 |
Alzheimer Disease |
|
Lithium |
3.50 | 19621015 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.11 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.29 | 19183758 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
3.36 | 17069543 18685284 |
MESH:D001714 |
Bipolar Disorder |
|
Lithium |
4.40 | 19153942 20338123 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.21 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.87 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.88 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.88 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
1.97 | 21507988 12619106 12907637 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.09 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.45 | 18850075 18670907 16120746 |
MESH:D002389 |
Catatonia |
|
olanzapine |
6.51 | 16772815 18071103 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.94 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.94 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.04 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.16 | 12621046 8697196 15668235 16354765 15340226 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 10048152 15322242 |
MESH:D007644 |
Darier Disease |
|
Lithium |
6.15 | 20338123 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.80 | 17069543 |
MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
5.96 | 19244398 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.70 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.57 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.89 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.55 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.17 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.48 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.48 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.03 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.21 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.21 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.46 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
11.75 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
11.75 | 19638421 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
11.75 | 11294989 10048152 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.66 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.11 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 16354765 8697196 16959395 18606429 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
6.47 | 17933447 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.14 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.14 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.93 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.71 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.43 | 18776723 8314463 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.88 | 12371664 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.72 | 18177683 15890375 2125692 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.72 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.72 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.15 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.15 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
4.86 | 20210726 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.45 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.45 | 20464547 17053015 20869020 18520028 18816296 20064080 18569708 20135361 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.45 | 11884234 19555203 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
4.87 | 16856516 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
5.56 | 19142110 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.05 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.32 | 16381670 |
MESH:D009203 |
Myocardial Infarction |
|
Lithium |
3.98 | 16288908 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.16 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.24 | 11141357 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.71 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.44 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.41 | 14600291 |
MESH:D009765 |
Obesity |
|
olanzapine |
3.75 | 18515891 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.37 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.43 | 11896295 11118676 11399792 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.94 | 17292933 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.28 | 16882103 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
5.80 | 18685284 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
3.45 | 20521326 20107430 17726453 |
MESH:D012640 |
Seizures |
|
Lithium |
4.09 | 19660546 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.72 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.72 | 16192470 |
MESH:D013226 |
Status Epilepticus |
|
Lithium |
6.05 | 19951488 19570321 19430551 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
OMIM:609161 |
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT |
marker/mechanism |
|
| |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
5.53 | 20210726 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.23 | 17053015 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.25 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
5.32 | 17933447 20107430 19434072 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.71 | 17120751 |